Table 8.

Cox regression models for 30-day and 1-year all-cause mortality excluding patients who received transapical access

	Univariate			Multivariate
	HR	95% CI	p value	HR	95% CI	p value
30-day all-cause mortality
EUROSCORE II	1.15	1.07–1.24	< 0.001	1.13	1.05–1.21	0.002
AKI	2.17	1.75–6.25	0.022	1.44	0.48–4.36	0.514
Vascular complications	3.11	1.04–9.28	0.042	1.06	0.24–4.66	0.938
Life-threatening/major bleeding complications	8.47	2.84–25.28	< 0.001	6.20	1.37–28.06	0.018
PPMI	3.47	0.45–26.53	0.230	–	–	–
1-year all-cause mortality
EUROSCORE II	1.08	1.02–1.15	0.005	1.07	1.02–1.15	0.034
AKI	2.29	1.27–4.15	0.006	1.27	1.13–3.06	0.020
Baseline CrCl	0.97	0.95–0.99	0.011	0.99	0.96–1.02	0.132
Baseline NT-proBNP	1.01	1.01–1.02	0.006	1.00	0.99–1.01	0.198
Life-threatening/major bleeding complications	4.97	2.39–10.35	< 0.001	3.99	0.91–11.79	0.069
PPMI	2.19	0.86–5.55	0.098	–	–	–

AKI acute kidney injury, BNP brain natriuretic peptide, CrCl creatinine clearance, PPMI post-procedure myocardial injury